MedTrace Logo

Validation of Ferromagnetic Tracer in Melanoma Sentinel Node

NCT03449615 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 186

Last updated 2018-03-01

No results posted yet for this study

Summary

This study has been designed to validate a non-radioactive method to identify the sentinel lymph node using a superparamagnetic iron-oxide (SPIO) tracer respect to the traditional isotopic method. Both methods are used in every included patient and each patient is its own control.

Conditions

  • Melanoma Stage
  • Sentinel Lymph Node

Sponsors & Collaborators

  • Sysmex España

    collaborator INDUSTRY

  • Sociedad Española de Oncología Quirúrgica

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-12-21
Primary Completion
2018-05-31
Completion
2018-09-30

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03449615 on ClinicalTrials.gov